• 您现在的位置: 主页 / 其他重组蛋白 / Cynomolgus NKG2A&CD94 Protein, Accession: Q68VD2(NKG2A)&Q68V. (watson-bio.cn)
  • Recombinant Cynomolgus NKG2A&CD94 Protein is expressed from HEK293 with His tag and Flag tag at the C-terminal.It contains Pro94-Leu233(NKG2A)&Lys32-Ile179(CD94). (watson-bio.cn)
  • Immobilized Cynomolgus NKG2A&CD94, His Tag at 1ug/ml (100ul/well) on the plate. (watson-bio.cn)
  • On healthy cells the non-classical HLA class Ib molecule HLA-E displays the cognate ligand for the NK cell receptor NKG2A/CD94 when bound to HLA class I signal peptide sequences. (mpg.de)
  • In the present study we have evaluated the molecular basis for the impaired NK cell inhibition by these peptides and determined the cell surface stability of individual p:HLA-E complexes and their binding efficiency to soluble NKG2A/CD94 or NKG2C/CD94 receptors. (mpg.de)
  • However, the contributions to immune evasion of HLA-E, a ligand for the inhibitory CD94/NKG2A receptor, when expressed on tumors, compared with adjacent tissue and peripheral blood mononuclear cells, remains unclear. (ox.ac.uk)
  • We also found that the presence of CD94/NKG2A on human tumor-specific T cells impairs IL2 receptor-dependent proliferation, which affects IFNγ-mediated responses and antitumor cytotoxicity. (ox.ac.uk)
  • Binding of the CD94/NKG2A receptor by its ligand (Qa-1(b)) did not significantly inhibit CD8(+) T cell effector functions. (duke.edu)
  • In a pathogenic situation when HLA class I is absent, HLA-E is bound to a diverse set of peptides and enables the stimulatory NKG2C/CD94 receptor to bind. (mpg.de)
  • Activated synovial NK cells produced interferon-gamma and tumour necrosis factor, and the production was further up-regulated by antibody masking of CD94/NKG2A, and down-regulated by target cells expressing human leucocyte antigen-E in complex with peptides known to engage CD94/NKG2A. (ox.ac.uk)
  • We show that non-canonical peptides provide stable cell surface expression of HLA-E, and these p:HLA-E complexes still bind to NKG2/CD94 receptors in a peptide-restricted fashion. (mpg.de)
  • Activating and inhibitory receptors on synovial fluid natural killer cells of arthritis patients: role of CD94/NKG2A in control of cytokine secretion. (ox.ac.uk)
  • Our results suggest that enriched HLA-E:CD94/NKG2A inhibitory interaction can impair survival of PD-1high TILs in the tumor microenvironment. (ox.ac.uk)
  • We conclude that synovial NK cells have an activated phenotype and that CD94/NKG2A is a key regulator of synovial NK-cell cytokine synthesis. (ox.ac.uk)
  • The expression of CD94/NKG2A was rapidly initiated in naive CD8(+) T cells responding to peptide Ags in vitro and on many of the naive T cells that proliferate when transferred into lymphopenic (Rag-1(-/-)) hosts. (duke.edu)
  • These subtle effects suggest that CD94/NKG2A-mediated inhibition of T cells may be limited to particular circumstances or may synergize with other receptors that are similarly up-regulated. (duke.edu)
  • Thus, CD94/NKG2A expression is a common consequence of CD8(+) T cell activation. (duke.edu)
  • However, expression of CD94 and NKG2A transgenes partially inhibited early events of T cell activation. (duke.edu)
  • CD94/NKG2A is exclusively expressed on PD-1high TILs while lacking intratumoral CD103 expression. (ox.ac.uk)
  • CD94/NKG2A complexes are also found on a subset of CD8+ T cells. (rndsystems.com)
  • Most human NK cells express inhibitory receptors specific for HLA class I molecules including the clonally distributed killer immunoglobulin-like receptors (KIRs), that are able to distinguish among different HLA-A, -B and -C allotypes, [ 2 ] and the CD94/NKG2A heterodimer that is specific for HLA-E ( Table 1 ). (medscape.com)
  • Interestingly, HCMV encodes a glycoprotein UL40, which increases the expression of HLA-E on the surface of virus-infected cells and thus their resistance to killing by CD94/NKG2A + NK cells. (medscape.com)
  • DNA sequence encoding Human NKG2A&CD94 including a N-His-Avi tag was expressed in HEK293 Cells. (reprokine.com)
  • Recombinant Human NKG2A&CD94 is a protein consisting of amino acid residues [Arg100-Leu233(NKG2A) & Ser34-Ile179(CD94)] ,The protein has a predicted MW of 17.9 kDa (CD94)&18.3 kDa (NKG2A). (reprokine.com)
  • Biotinylated Human NKG2A&CD94 on Tris-Bis PAGE under reduced condition. (reprokine.com)
  • The purity of Biotinylated Human NKG2A&CD94 is greater than 95% as determined by SEC-HPLC. (reprokine.com)
  • Dose response curve for Biotinylated Human NKG2A&CD94, His Tag with the EC50 of 0.11μg/ml determined by ELISA. (reprokine.com)
  • CD94/NKG2A and killer immunoglobulin-like receptors (KIR)) that recognize MHC class I molecules. (hindawi.com)
  • Target cell pre-activation significantly enhanced CD8+ T granule-mediated cell killing of CD4+ targets, and was restricted by HLA-E. During exacerbations, killer-inhibitory receptor CD94/NKG2A expression was significantly higher in CD8+ TCCs, limiting their cytotoxic activity. (nih.gov)
  • Moreover, IL-15 and IFN-gamma significantly increased CD94 and NKG2A expression. (nih.gov)
  • These data provide evidence that CD94/NKG2A receptors play an important role in regulating T cell activity during the course of MS. (nih.gov)
  • The result of 0.2 ng/ml IL12 in the expression from the CD94, NKG2C and NKG2A receptor stores was analyzed by stream cytometry in gated Compact disc56+ cells. (sciencepop.org)
  • In contrast CD56bright NK cells mostly lack the expression of these receptors but reveal to a high percentage expression of the inhibitory receptor CD94/NKG2A. (sciencepop.org)
  • Mouse Cd94 and Nkg2a mRNA were detectable in splenocytes of wild-type (+/+) mice. (biocytogen.jp)
  • Human CD94 and NKG2A mRNA were detectable only in the homozygous B-hCD94/hNKG2A, but not in +/+ mice. (biocytogen.jp)
  • Splenocytes were collected from WT and homozygous B-hCD94/hNKG2A (H/H) mice, and analyzed by flow cytometry with species-specific CD94 or NKG2A antibody. (biocytogen.jp)
  • Mouse CD94 and NKG2A were detectable in WT mice. (biocytogen.jp)
  • Human CD94 and NKG2A were exclusively detectable in homozygous B-hCD94/hNKG2A but not WT mice. (biocytogen.jp)
  • The type-II transmembrane glycoprotein CD94 covalently associates with C-type lectins of the NKG2 family to yield heterodimers important in NK cell recognition of class I MHC molecules. (rndsystems.com)
  • Expression of CD94/NKG2 heterodimers may regulate cell survival and effector functions. (rndsystems.com)
  • KLRD1 (CD94) is an antigen preferentially expressed on NK cells and is classified as a type II membrane protein because it has an external C terminus. (nih.gov)
  • There are two alternatively spliced variants of CD94 that differ by 31 amino acids encoded by exon 2. (rndsystems.com)
  • 5. Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. (nih.gov)
  • Human CD94 were exclusively detectable in activated CD8+ T cells of homozygous B-hCD94/hNKG2A mice after treated with mCD3e 24h. (biocytogen.jp)